Lee Gary K.

Chief Scientific Officer at LYEL

Sold, on record
$90k
Dollars the filings state
Form 4 sales
8
Latest Aug 21, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LYELLyell Immunopharma, Inc.Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
3
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale LYELNo plan
    Aug 12, 2025 2025

    Sold 267 shares at $10.43 ($3k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 2.9% of holdings ($96k position)8,957 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LYELNo plan
    Aug 21, 2025 +9 days

    Sold 1,453 shares at $10.54 ($15k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 8.6% of holdings ($179k position)15,504 shares leftFiling

  3. 3 Form 4 sale LYELNo plan
    Nov 10, 2025 +81 days

    Sold 138 shares at $16.16 ($2k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 0.9% of holdings ($251k position)15,366 shares leftFiling

  4. 4 Form 4 sale LYELNo plan
    Feb 10, 2026 +92 days

    Sold 147 shares at $23.12 ($3k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 0.8% of holdings ($434k position)18,609 shares left0.6x usual sizeFiling

  5. 5 Form 4 sale LYELUnusual
    Feb 11, 2026 +1 day

    Sold 1,671 shares at $23.39 ($39k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 9% of holdings ($435k position)16,938 shares left8.1x usual sizeFiling

  6. 6 Form 4 sale LYELNo plan
    May 11, 2026 +89 days

    Sold 130 shares at $18.92 ($2k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 0.7% of holdings ($339k position)17,808 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale LYELNo plan
    Aug 10, 2026 +91 days

    Sold 131 shares at $14.34 ($2k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 0.7% of holdings ($255k position)17,677 shares left0.6x usual sizeFiling

  8. 8 Form 4 sale LYELUnusual
    Aug 21, 2026 +11 days

    Sold 1,457 shares at $15.54 ($23k)

    Lee Gary K., Chief Scientific Officer

    No 10b5-1 planSold 8.2% of holdings ($275k position)16,220 shares left9.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Lee Gary K.
Source
Aug 21, 2026Aug 25, 2026LYELChief Scientific OfficerForm 4 sale1,457$23k8.2%UnusualSEC
Aug 10, 2026Aug 11, 2026LYELChief Scientific OfficerForm 4 sale131$2k0.7%No planSEC
May 11, 2026Jun 15, 2026LYELChief Scientific OfficerForm 4 sale130$2k0.7%No planSEC
Feb 11, 2026Feb 12, 2026LYELChief Scientific OfficerForm 4 sale1,671$39k9.0%UnusualSEC
Feb 10, 2026Feb 11, 2026LYELChief Scientific OfficerForm 4 sale147$3k0.8%No planSEC
Nov 10, 2025Nov 12, 2025LYELChief Scientific OfficerForm 4 sale138$2k0.9%No planSEC
Aug 21, 2025Aug 22, 2025LYELChief Scientific OfficerForm 4 sale1,453$15k8.6%No planSEC
Aug 12, 2025Aug 13, 2025LYELChief Scientific OfficerForm 4 sale267$3k2.9%No planSEC